causal
Redundant clinical trials waste resources
When an immune therapy is approved for one cancer, rather than running one trial to test it elsewhere, thousands of redundant trials (e.g., 2200) ask the same question—each costing millions, with Phase One around $25 million and Phase Three from $500 million to $2.5 billion—so a 'me too' rush to make money stifles creativity and the development of novel targets.
causalpending
Speaker
Azra RazaEvidence Quote
“there are 2200 trials going on to ask the same question... Phase One costs $25 million, and Phase Three costs anywhere from $500 million to $2.5 billion dollars.”
Created: 6/13/2026, 12:20:51 AM
Your notes
Loading notes...